DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-8.18%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.15B
AUM Growth
+$3.15B
(+0.62%)
Cap. Flow
+$240M
Cap. Flow
% of AUM
7.63%
Top 10 Holdings %
Top 10 Hldgs %
42.21%
Holding
105
New
27
Increased
25
Reduced
19
Closed
17
Top Buys
| 1 |
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
|
$103M |
| 2 |
Viatris
VTRS
|
$59.6M |
| 3 |
Schrodinger
SDGR
|
$58M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
$54.6M |
| 5 |
Pacira BioSciences
PCRX
|
$54.6M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$92.3M |
| 2 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$71.3M |
| 3 |
Tandem Diabetes Care
TNDM
|
$61M |
| 4 |
Protara Therapeutics
TARA
|
$36.7M |
| 5 |
Humana
HUM
|
$30.1M |
Sector Composition
| 1 | Healthcare | 71.83% |
| 2 | Technology | 0.07% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AdaptHealth
AHCO
$1.28B
| $275M | 8.73% | 17,199,888 | – | – |
|
|
2
Viatris
VTRS
$12.3B
| $181M | 5.75% | 12,151,362 +3,999,608 | +49% | +$59.6M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $174M | 5.54% | 5,888,511 +1,146,200 | +24% | +$34M |
|
|
DFPHU
4
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $103M | 3.27% | +10,460,000 | New | +$103M |
|
5
Centene
CNC
$14.3B
| $75.3M | 2.39% | 1,267,206 +158,806 | +14% | +$9.43M |
|
|
ORTX
6
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $66.7M | 2.12% | 8,862,247 | – | – |
|
7
Q32 Bio
QTTB
$20.9M
| $62.7M | 1.99% | 4,037,305 -1,208,333 | -23% | -$18.8M |
|
|
8
Schrodinger
SDGR
$1.44B
| $58M | 1.84% | +1,346,167 | New | +$58M |
|
9
Brookdale Senior Living
BKD
$1.83B
| $57.4M | 1.82% | 18,402,355 +11,178,936 | +155% | +$34.9M |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $55.4M | 1.76% | 4,107,464 +2,384,846 | +138% | +$32.1M |
|
|
ABMD
11
DELISTED
Abiomed Inc
ABMD
| $54.6M | 1.73% | +376,000 | New | +$54.6M |
|
|
12
Pacira BioSciences
PCRX
$1.2B
| $54.6M | 1.73% | +1,627,521 | New | +$54.6M |
|
13
Arvinas
ARVN
$568M
| $48.9M | 1.55% | 1,212,922 +124,688 | +11% | +$5.02M |
|
14
Mirum Pharmaceuticals
MIRM
$3.71B
| $48.3M | 1.53% | 3,448,912 | – | – |
|
15
Rhythm Pharmaceuticals
RYTM
$6.85B
| $46.1M | 1.46% | 3,031,565 -1,257,726 | -29% | -$19.1M |
|
|
AXNX
16
DELISTED
Axonics, Inc. Common Stock
AXNX
| $45.6M | 1.45% | 1,794,594 +956,649 | +114% | +$24.3M |
|
|
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $42.4M | 1.35% | 1,348,000 +68,520 | +5% | +$2.16M |
|
18
Alector
ALEC
$238M
| $42M | 1.33% | 1,738,997 -337,815 | -16% | -$8.15M |
|
19
Vericel Corp
VCEL
$1.83B
| $40.8M | 1.29% | 4,447,109 +1,699,546 | +62% | +$15.6M |
|
20
Revolution Medicines
RVMD
$7.1B
| $39.4M | 1.25% | +1,796,383 | New | +$39.4M |
|
21
Natera
NTRA
$23.1B
| $39.3M | 1.25% | +1,316,000 | New | +$39.3M |
|
22
Fate Therapeutics
FATE
$120M
| $35.9M | 1.14% | 1,616,993 -385,612 | -19% | -$8.56M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $34.2M | 1.08% | 2,532,147 +759,892 | +43% | +$10.3M |
|
|
XENT
24
DELISTED
Intersect ENT, Inc
XENT
| $32.7M | 1.04% | 2,758,267 -38,766 | -1% | -$459K |
|
|
XLRN
25
DELISTED
Acceleron Pharma Inc.
XLRN
| $30.8M | 0.98% | 343,000 -1,026,625 | -75% | -$92.3M |
|